Yahoo
NasdaqGM - Delayed Quote USD

VanEck Pharmaceutical ETF (PPH)

119.33 +2.41 (+2.06%)
At close: 4:00:00 PM EDT
Trade PPH on Coinbase
Chart Range Bar
Loading chart for PPH
  • Previous Close 116.92
  • Open 119.73
  • Bid 109.61 x 100
  • Ask 110.12 x 100
  • Day's Range 118.96 - 120.86
  • 52 Week Range 91.55 - 120.86
  • Volume 1,276,660
  • Avg. Volume 306,176
  • Net Assets 1.02B
  • NAV 116.91
  • PE Ratio (TTM) 27.28
  • Yield 1.99%
  • YTD Daily Total Return 15.29%
  • Beta (5Y Monthly) 0.43
  • Expense Ratio (net) 0.36%

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

VanEck

Fund Family

Health

Fund Category

1.02B

Net Assets

2011-12-20

Inception Date

Performance Overview

View More

Trailing returns as of 10/29/2026. Category is Health.

YTD Return

PPH
15.29%
Category
2.39%

1-Year Return

PPH
31.14%
Category
21.31%

3-Year Return

PPH
18.64%
Category
6.58%

People Also Watch

Research Reports

View More
  • Initiating coverage on HHH

    Howard Hughes Holdings Inc has an Investment Rating of HOLD; a target price of $77.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.

  • Daily – Vickers Top Buyers & Sellers for 09/25/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Verisign to Continue to Benefit as Operator of Some of the Internet’s Most Valuable Real Estate

    Verisign is an operator of critical infrastructure within the domain name system, or DNS. As the registry for some of the world’s most popular TLDs, .com and .net, Verisign directs DNS resolvers to the appropriate registry where IP addresses are stored. Verisign’s control over its TLDs is regulated by ICANN and the NTIA and are subject to contract renewal every six years. The company generates revenue through annual subscriptions allowing customers to use .com and .net as their TLD of choice for their respective websites.

  • Vornado Realty Trust: Dropping Coverage

    Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: